Evidence map›Paper›PMID 39175038›Full record

ArticleReproductive biology and endocrinology : RB&E2024

Effect of LH level on HCG trigger day on clinical outcomes in patients with diminished ovarian reserve undergoing GnRH-antagonist protocol.

Qianjie Zhang, Kexin Zhang, Yu Gao, Shaojing He, Yicen Meng, Lei Ming, Tailang Yin, Jing Yang, Shuang Wu, Zhongming Zhou and 2 more

Abstract read
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qianjie Zhang *Reproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Kexin Zhang *Reproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Yu GaoReproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Shaojing HeReproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Yicen MengReproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Lei MingReproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Tailang YinReproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Jing YangReproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Shuang WuHubei Provincial Hospital of Traditional Chinese Medicine Affiliated to Hubei University of Traditional Chinese Medicine, Wuhan, 430060, China.
Zhongming ZhouHubei Provincial Hospital of Traditional Chinese Medicine Affiliated to Hubei University of Traditional Chinese Medicine, Wuhan, 430060, China.
Wei LiDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. 137299105@qq.com.
Saijiao LiReproductive Medical Center, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Renmin Hospital of Wuhan University, Wuhan, 430060, China. alva_whu@hotmail.com.

Funding

Health Commission of Hubei Province WJ2021M158Joint Fund project of Hubei Province 2022CFD155National Natural Science Foundation of China N81701412Natural Science Foundation of Hubei Province 2018CFB491
6 · The paper itself

Abstract

research questionDoes luteinizing hormone (LH) levels on human chorionic gonadotropin (HCG) trigger day (LH

methodsRetrospective analysis fresh embryo transfer cycles of DOR patients who underwent GnRH-ant protocol from August 2019 to June 2023. The participants were divided into different groups according to LH

resultsIn patients with DOR, the HCG positive rate (59.3% versus 39.8%, P = 0.005), embryo implantation rate (34.5% versus 19.7%, P = 0.002), clinical pregnancy rate (49.2% versus 28.4%, P = 0.003), live birth rate (41.5% versus 22.7%, P = 0.005) in LH

conclusionsLH

Indexed as

Chorionic GonadotropinEmbryo TransferGonadotropin-Releasing HormoneLuteinizing HormoneOvarian ReserveOvulation InductionPregnancy RateAdultFemaleFertilization in VitroHormone AntagonistsHumansInfertility, FemalePregnancyPregnancy OutcomeRetrospective StudiesChorionic GonadotropinGonadotropin-Releasing HormoneHormone AntagonistsLuteinizing HormoneDiminished ovarian reserveGnRH-antagonist protocolLuteinizing hormone on HCG dayPOSEIDON criteria

Identifiers

PMID39175038
PMCPMC11340131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.